Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Health Care Services

Labcorp stock buybacks

LH
$702Mbought back in the 12 months to Jun 30, 2026

Labcorp bought back $702M of its stock in the last twelve months, $576M more than it paid out in stock compensation. Its share count is down 2.3% from a year earlier.

Stock repurchases by quarter
−$10M$0$600M$1.2BQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q2 '26
Show as table
PeriodValue
Q3 '20$0
Q4 '20$0
Q1 '21$68.5M
Q2 '21$300M
Q3 '21$300M
Q4 '21$1B
Q1 '22$0
Q2 '22$400M
Q3 '22$800M
Q4 '22$300M
Q1 '23$0
Q2 '23$0
Q3 '23$1.0B
Q4 '23−$9M
Q1 '24$0
Q2 '24$0
Q3 '24$75M
Q4 '24$75.1M
Q1 '25$0
Q2 '25$200M
Q3 '25$25M
Q4 '25$225M
Q1 '26$98M
Q2 '26$353.8M
Diluted shares outstanding
82.8M90.5M98.2MQ3 '20Q3 '21Q3 '22Q3 '23Q3 '24Q3 '25Q2 '26
Show as table
PeriodValue
Q3 '2098.1M
Q4 '2099.0M
Q1 '2198.5M
Q2 '2198.2M
Q3 '2197.1M
Q4 '2196.2M
Q1 '2294.0M
Q2 '2292.7M
Q3 '2290.7M
Q4 '2289.0M
Q1 '2389.0M
Q2 '2389.0M
Q3 '2387.0M
Q4 '2385.4M
Q1 '2484.7M
Q2 '2484.3M
Q3 '2484.4M
Q4 '2484.2M
Q1 '2584.3M
Q2 '2583.9M
Q3 '2583.7M
Q4 '2583.3M
Q1 '2682.9M
Q2 '2682.0M
$354Mlast quarter (Q2 2026)
$576Mnet of stock compensation ($126M)
−2.3%diluted shares, 1 year
−14.5%diluted shares, 5 years
$239Mdividends, 12 months
61%of free cash flow ($1.2B) spent on buybacks
$0raised by issuing stock, 12 months
$379Mleft under its authorization as of Jun 30, 2026

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2025$450M$241M$126M$1.2B83.8M10-K
2024$250M$243M$117M$1.1B84.4M10-K
2023$1.0B$254M$129M$874M87.6M10-K
2022$1.1B$195M$117M$1.5B91.6M10-K
2021$1.7B—$133M$2.7B97.5M10-K
2020$100M—$112M$1.8B98.0M10-K
2019$450M—$107M$1.0B98.6M10-K
2018$700M—$92M$926M102.6M10-K
2017$338M—$110M$1.2B103.9M10-K
2016$44M—$110M$918M104.3M10-K

Questions

Does Labcorp buy back its stock?
Labcorp bought back $702M of its stock in the last twelve months, $576M more than it paid out in stock compensation. Its share count is down 2.3% from a year earlier.
How much did Labcorp spend on buybacks in fiscal 2025?
$450M, according to its 10-K for the fiscal year ending Dec 31, 2025.
Is Labcorp's share count going down?
Its diluted share count changed −14.5% over five fiscal years and −2.3% over the last year.
Does Labcorp have a buyback authorization?
Its filings show $379M remaining under its repurchase authorization as of Jun 30, 2026.

Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 5, 2026 · open on SEC.gov

Other Health Care companies